SOJOURN

This brand name is authorized in United States. It is also authorized in Canada, Croatia, Ecuador, France, Hong Kong SAR China, Poland, Romania, Singapore, South Africa, Turkey.

Active ingredients

The drug SOJOURN contains one active pharmaceutical ingredient (API):

1	Sevoflurane UNII 38LVP0K73A - SEVOFLURANE
	Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness.
	Read more about Sevoflurane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AB08	Sevoflurane	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AB Halogenated hydrocarbons
Discover more medicines within N01AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02307766
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28862-05-09
FR	Base de données publique des médicaments	60654271
HK	Department of Health Drug Office	56752
HR	Agencija za lijekove i medicinske proizvode	HR-H-382308710
PL	Rejestru Produktów Leczniczych	100041869
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67161001, W67161002
SG	Health Sciences Authority	14780P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699587523112
US	FDA, National Drug Code	66794-012
ZA	Health Products Regulatory Authority	41/2.1/0098